Bausch Health Companies | Fremdkapital



Loan Capital Veränderung Datum
Amgen USD 54.01B 2.54B 2025-03
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Danaher USD 15.98B 476M 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
Novo Nordisk 96.31B 44.86B 2025-03
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.58B 730.9M 2024-12
Prestige Brands USD 1.01B 16.93M 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.23B 7M 2025-03



Bausch Health Companies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.